Timo Minssen (Former)
31 – 40 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The problem with antibiotics
- Contribution to journal › Article
-
Mark
Is Data Sharing Caring Enough About Patient Privacy?: Part I: The Background
(2019)
- Other contribution › Miscellaneous
-
Mark
What lurks in the shadows of the openness hyperbole for biopharmaceuticals?
(2019) In Drug Development Research
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine
- Contribution to journal › Article
-
Mark
An Update on Research- & Bolar exemptions in the U.S. and Europe: Unsolved questions and new developments in an increasingly important area of law
- Contribution to journal › Article
-
Mark
Global Genes, Local Concerns: Legal, Ethical and Scientific Challenges in International Biobanking
(2019)
- Book/Report › Book
-
Mark
Much ado about something. Legal, ethical, and scientific challenges in international biobanking and translational exploitation
(2019) 1.
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Shadow health records meet new data privacy laws
- Contribution to journal › Article
-
Mark
An "export-only" exception to pharmaceutical patents in Europe: Should the U.S. follow suit?
- Contribution to journal › Article
-
Mark
Nudges or Shoves in the Secondary Use of Health Data: What is the More Desirable Approach? (Part 2)
(2019)
- Other contribution › Miscellaneous